mpharm_oct2011

Views:
 
Category: Education
     
 

Presentation Description

M.Pharma Previous Question papers

Comments

Presentation Transcript

slide 1:

Total No. of Questions : 6 Total No. of Pages :2 4056 - 101 M. Pharmacy ADVANCED ANALYTICAL TECHNIQUES 2008 Pattern Sem. - I Time : 3 Hours Max Marks : 80 Instructions to candidates : 1 Question 1 and 4 are Compulsory. 2 Attempt any one question from the remaining in section I and any one question from the remaining questions of section II. 3 Answers to the two sections should be written on the separate books. 4 Draw diagram whenever necessary. 5 Figures to the right indicate full marks. SECTION-I Q1 a Suggest suitable chemical structural formula for following spectroscopic data: 8 MF C 5 H 12 O Transparent to UV IR : 3480 2970 1150 cm -1 Proton NMR: 0.9 triplet 3H 1.14 singlet 6H 1.48 quartet 2H 3.2 singlet 1H b Explain instrumentation and applications of powder X-ray diffraction. 8 c Comment on energy transitions in NMR spectroscopy. 4 Q2 a Discuss various energy transitions in a molecule after absorption of UV radiations with suitable example. 8 b Write theory instrumentation and applications of Differential Scanning Calorimetry. 8 c Comment on carbonyl IR absorption peak in acetaldehyde and acetone. 4 P.T.O. P 1671

slide 2:

Q3 a What is emission spectroscopy Discuss principle and applications of fluorescence phosphorescence and chemiluminescences. 8 b Explain interpretation of IR spectrum and fingerprint region in IR spectroscopy. 8 c Calculate absorption maxima of 4-chloro-2-methyl benzoic acid and 4-chloro-2-methyl benzaldehyde. 4 SECTION-II Q4 a Compare contrast different aspects of TLC and HPTLC techniques. 10 b Elaborate on API mass spectral technique. Explain how fragmentation takes place in CIMS. 10 Q5 a What is a stability indicating HPLC method of analysis Explain in detail how it is validated as per ICH guidelines 14 b Elaborate on what is “head space GC” Give two important applications of the same in analysis. 6 Q6 a Explain in depth which parameters are considered important in selecting a HPLC UV detector. 8 b Illustrate with the help of fragmentation how 1-pentanol 2-pentanol and 2-methy1-2-butanol can be identified with the help of EIMS.12 4056-101 - 2 -

slide 3:

Total No. of Questions : 6 Total No. of Pages :1 4056 - 102 M. Pharmacy Sem. - I RESEARCH METHODOLOGY 2008 Pattern Time : 3 Hours Max Marks : 80 Instructions to candidates : 1 Attempt any two questions from Section-I and any two questions from Section- II. 2 Answers to the two sections should be written in separate answer books. 3 All questions carry equal marks. SECTION-I Q1 What is research Discuss in detail the different types of research. 20 Q2 Discuss the different sources of research problems. Explain the importance of selection and formulation of research problem. 20 Q3 Write notes on any two of the following: 20 a Use of computer packages in documentation. b Student‘t’ test. c Correlation data. SECTION-II Q4 Give the detailed account of data analysis techniques employed in scientific research. 20 Q5 Why protection is needed on intellectual property. Give the detailed account of historical development of concept of intellectual property rights. 20 Q6 Write notes on any two of the following: 20 a Use of bibliography in research. b Importance of literature survey in research. c ANOVA. P 1672

slide 4:

Total No. of Questions : 6 Total No. of Pages :1 4056 - 103 M. Pharmacy ADVANCED PHARMACEUTICS 2008 Pattern Sem. - I Time : 3 Hours Max Marks : 80 Instructions to candidates : 1 Answer 2 questions from Section I and 2 questions from Section II. 2 Answers to the two sections should be written in separate books. 3 Neat diagrams must be drawn wherever necessary. 4 Figures to the right indicate full marks. SECTION-I Q1 What is Preformulation Give its significance and discuss physics of tablet Compression. 20 Q2 Explain in detail characterization of polymers. 20 Q3 Explain concept of Stability of pharmaceuticals discuss in detail statistical aspects in expiry period. 20 SECTION-II Q4 Explain the concept of quality control quality assurance and total quality management and discuss validation of pharmaceutical process with at least one case study. 20 Q5 Discuss the methods formulation and evaluation of microcapsules. 20 Q6 Write note on any two: 20 a Dissolution models. b Biodegradable Polymers. c Liquid crystal phase. P 1673

slide 5:

Total No. of Questions : 8 Total No. of Pages :1 4056 - 104 M. Pharmacy Sem. - I ADVANCED PHARMACEUTICAL CHEMISTRY 2008 Pattern Time : 3 Hours Max Marks : 80 Instruction to the candidates : Question Nos. 01 and 05 are Compulsory. Out of the remaining attempt 2 questions from Section I and 2 questions from Section II. SECTION-I Q1 Explain conformational isomerism with examples. 10 Q2 What are chiral drugs Explain asymmetric synthesis of Nifedipine. 15 Q3 Explain wittig reaction along with reaction mechanism stereochemistry and application. 15 Q4 Write note on any two: 15 a Ionic liquids. b Solvent free reactions using microwave technology. c Free radical reactions. SECTION-II Q5 Define synthon. Explain the rules for disconnection of heteroatoms in synthon approach with examples. 10 Q6 Give two methods of asymmetric synthesis. 15 Q7 What are FGI’s Give the synthon approach to the synthesis of Losartan.15 Q8 Write note on any two: 15 a Birch reduction. b Optical isomerism. c Water as solvent. P 1674

slide 6:

Total No. of Questions : 8 Total No. of Pages : 2 4056-208 M. Pharmacy Sem. - II PHYTOCHEMISTRY PHYTOPHARMACEUTICALS 2008 Pattern Time : 3 Hours Max. Marks : 80 1 Question No. 1 and 5 are compulsory. " 4 Figures to the right indicate full marks. P1695 " ’ +’-

slide 7:

. ’

slide 8:

Total No. of Questions : 8 Total No. of Pages : 1 4056-209 M. Pharmacy Sem. - II INDUSTRIAL PHARMACOGNOSY 2008 Pattern Time : 3 Hours Max. Marks : 80 1 Question Nos. 1 and 5 are compulsory. Out of the remaining attempt 2 questions from Section I and 2 questions from Section II. 3 Neat diagrams must be drawn wherever necessary. P1696 " ’ ’ "

slide 9:

Total No. of Questions : 6 Total No. of Pages : 1 4056-210 M. Pharmacy Sem. - II PHARMACEUTICAL VALIDATION 2008 Pattern Time : 3 Hours Max. Marks : 80 1 Question No. 1 and 4 are compulsory. Out of the remaining attempt any one question from Section I and II respectively 3 Neat diagrams must be drawn wherever necessary. 4 Figures to the right indicate full marks. P1697 " ’

slide 10:

Total No. of Questions : 8 Total No. of Pages : 1 4056-211 M. Pharmacy Sem. - II QUALITY PLANNING AND ANALYSIS Theory 2008 Pattern Time : 3 Hours Max. Marks : 80 1 Question No. 1 and 5 are compulsory. 3 Answers to the two sections should be written on separate answer books. 4 Figures to the write indicate full marks. P1698 "" " ’ " + ’+ -" "+ -+ ’+

slide 11:

" ’ " ’ " ""+ "-"" Total No. of Questions :6 Total No. of Pages :1 4056 - 105 M.Pharmacy Sem. - I ADVANCED PHARMACOLOGY - I Preclinical Evaluation of Drugs 2008 Pattern P1675

slide 12:

" ’ Total No. of Questions :8 Total No. of Pages :2 4056 - 106 M.Pharmacy Sem. - I ADVANCED PHARMACOGNOSY - I 2008 Pattern "" " ’ "" P1676 P.T.O.

slide 13:

" ’ ’ +-."-. 4056-106 2

slide 14:

" " ’ Total No. of Questions :8 Total No. of Pages :2 4056 - 108 M.Pharmacy QUALITY CONTROL ASSURANCE OF PHARMACEUTICALS 2008 Pattern Commonto Sem. - I and Sem. - II "" P1677 P.T.O.

slide 15:

" + " ’ - 4056-108 2

slide 16:

" Total No. of Questions : 6 Total No. of Pages :1 4056 - 109 M.Pharmacy Common to Sem. - I II PHARMACEUTICAL PLANT DESIGN OPERATIONS 2008 Pattern " P1678

slide 17:

" ’ Total No. of Questions :8 Total No. of Pages :2 4056 - 110 M.Pharmacy BIOPHARMACEUTICS AND PHARMACOKINETICS 2008 Pattern Common To Sem. - I and Sem. - II " ’’ + P1679 P.T.O.

slide 18:

4056-110 2 +"+ "

slide 19:

" Total No. of Questions :8 Total No. of Pages :2 4056 - 111 M.Pharmacy STERILE PRODUCTS FORMULATION AND TECHNOLOGY 2008 Pattern Common To Sem. - I and Sem. - II "’ ’ ’’"’’ + ’’ -+ ."" P1680 P.T.O.

slide 20:

4056-111 2 ’ ’ +’ +-

slide 21:

" Total No. of Questions :8 Total No. of Pages :2 4056 - 112 M.Pharmacy CHEMISTRY OF MEDICINAL NATURAL PRODUCTS 2008 Pattern Common to Sem. - I Sem. - II " " ’ ’’ P1681 P.T.O.

slide 22:

4056-112 2 ’

slide 23:

" " "’ + " Total No. of Questions :8 Total No. of Pages :2 4056 - 113 M.Pharmacy ACTIVE PHARMACEUTICAL INGRADIENTS APIS Manufacturing Technology 2008 Pattern Common to Sem. - I Sem. - II "’ " +-"-’-"" P1682 P.T.O.

slide 24:

4056-113 2 - ./ + 0 - 1 2

slide 25:

Total No. of Questions : 6 Total No. of Pages : 2 4056-204 M.Pharmacy Sem. - II ADVANCED MEDICINAL CHEMISTRY 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Attempt any two questions from Section I and any two questions from Section II. 2 Write answers to section I and Section II in separate answer book. SECTION - I Q1 a Explain the microbial transformation of steroids with suitable examples. 15 b Write about supporters and linkers in combinatorial synthesis. 5 Q2 a What are the different types of receptors. Explain the adrenergic receptors. 15 b Write nomenclature of prostaglandins. 5 Q3 Write the reaction mechanism and principle involved in following synthesis Any two: 20 a Diphenhydramine. b Ethinyl estradiol. c Linezolide. SECTION - II Q4 a Discuss and compare the advantages and disadvantages of microbial transformation over chemical synthesis. 15 b Write a brief note on CADD. 5 P1691 P .T .O.

slide 26:

4056-204 2 Q5 a Highlight the features of models of cholinergic receptors. 15 b Write about receptor cloning. 5 Q6 Write notes on any two: 20 a Importance of gene therapy. b QSAR in drug design. c Enzyme inhibition.

slide 27:

Total No. of Questions : 6 Total No. of Pages : 2 4056-205 M.Pharmacy Sem. - II DRUG DESIGN Theory 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question No.1 and 4 are compulsory. 2 Answer any one question from Section I and any one question from Section II from the remaining. 3 Answers to the two sections should be written in separate answer books. 4 Figures to the right indicate full marks. SECTION - I Q1 Explain the importance of following in action of drug 20 a Physicochemical properties b Role of stereochemistry Q2 a Define the term prodrug. Elaborate various types of prodrugs with suitable examples. 10 b How is concept of prodrug applicable in drug design. 10 Q3 Discuss the Free Wilson method its principle methodology advantages disadvantages with suitable examples. 20 SECTION - II Q4 Explain the concept of Ligand based drug design methods and techniques involved in the ligand based drug design. 20 Q5 Explain in detail any one of the parameter used in the classical LFER method of QSAR viz lipophilic or steric or electronic. 20 P1692 P .T .O.

slide 28:

4056-205 2 Q6 Write short notes on any four: 20 a Energy minimization methods b Flexible docking c Cluster analysis d Molecular mechanics e Theory of drug action f Template forcing

slide 29:

Total No. of Questions : 8 Total No. of Pages : 1 4056-206 M.Pharmacy Sem. - II CLINICAL PHARMACOLOGY 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question number 1 5 are Compulsory. Out of the remaining attempt any two questions from Section - I and two questions from Section - II. 2 Answers to the two sections should be written in separate book. 3 Figures to the right indicate full marks. SECTION - I Q1 Discuss the pharmacotherapy of angina pectoris. 10 Q2 Write a detailed note on pharmacotherapy of neoplastic disorders. 15 Q3 Describe the clinical treatment of acute renal failure. Add a note on renal transplantation. 15 Q4 Write notes on: a Management of diarrhoea. b Pharmacotherapy of peptic ulcers. 15 SECTION - II Q5 Discuss in detail about the resistance to antibiotics. 10 Q6 Write a note on current concepts in the treatment of AIDS. 15 Q7 Explain the pharmacotherapy of asthma. 15 Q8 Write a note on: 15 a Management of hepatic cirrhosis b Vaccines and Sera. P1693

slide 30:

Total No. of Questions : 8 Total No. of Pages : 2 4056-207 M.Pharmacy Sem. - II MOLECULAR PHARMACOLOGY 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Q.1 Q.5 are Compulsory. 2 Solve any two questions from the remaining in Section I and Section II. 3 Figures to the right indicate full marks. 4 Write answers for Section I II in separate answer sheets. SECTION - I Q1 Discuss recent advances in GABA and benzodiazepine receptors research.10 Q2 Enlist various endogenous bioactive molecules and describe role of endothelium derived vascular substances and it’s modulators. 15 Q3 What do you mean by adhesion therapy Explain clinical implication of this therapy. 15 Q4 Write a note on any three a Opoid receptors b Neuropeptide and it’s modulators c Pharmacology of atrial peptides d Calcium channel modulators 15 P1694 P .T .O.

slide 31:

4056-207 2 SECTION - II Q5 Discuss concept of gene therapy and it’s use in hereditary diseases. 10 Q6 Explain role of Chronopharmacology in drug therapy. 15 Q7 Write a note on Pharmacological Clinical implications of apoptosis. 15 Q8 Justify role of human genome mapping in current drug research. 15

slide 32:

" ’ + " "-+. /. Total No. of Questions :6 Total No. of Pages :1 4056 - 107 M.Pharmacy Sem. - I ADVANCED QUALITY ASSURANCE TECHNIQUES - I 2008 Pattern P1701

slide 33:

Total No. of Questions : 6 Total No. of Pages : 1 4056 - 114 M.Pharmacy Common to Sem. - I II CLINICAL TRIALS 2008 Course Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Solve any two questions from each sections. 2 All questions carry equal marks. 3 Answers to each section shall be written in separate sheet. SECTION - I Q1 Enlist various statistical tests used in clinical trials. Add a note on sub-group analysis. 20 Q2 Enlist various documents of clinical trial protocol. Explain investigators brochure in details. 20 Q3 Justify role of nuremberg code and helsinki declaration in the ethical issues of clinical trials. 20 SECTION - II Q4 Describe various phases of clinical trials. 20 Q5 Discuss process of NDA and ANDA with examples. 20 Q6 Write about role responsibilities of stake holders of clinical trials. 20

slide 34:

Total No. of Questions : 8 Total No. of Pages : 1 4056 - 115 M.Pharmacy Common to Sem. - I II SAFETY PHARMACOLOGY 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question No. 1 and 5 are compulsory. Out of the remaining attempt any 2 questions from Section - I and 2 questions from Section - II. 2 Answers to the two sections should be written in separate books. 3 Figures to the right indicate full marks. SECTION - I Q1 Discuss the ICH regulatory guidelines for the new drug safety assessment. 10 Q2 Describe the study design and analysis of safety pharmacological data. 15 Q3 Discuss the principles and study design for acute toxicity studies in rodents. 15 Q4 Write a note on safety testing for dermatological products. 15 SECTION - II Q5 Write a note on Pharmacovigilance planning. 10 Q6 15 Q7 Discuss the safety testing for ocular toxicity study. 15 Q8 Write a note on : 15 a Female reproductive toxicity studies. b Risk-Benefit assessment of drugs.

slide 35:

Total No. of Questions : 12 Total No. of Pages : 2 4056 - 116 M.Pharmacy TRADITIONAL SYSTEMS OF MEDICINE AYURVEDIC FORMULATIONS 2008 Pattern Common to Sem. - I Sem. - II Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Section - I carries 6 questions of 10 marks each. Answer any four questions in Section - I. 2 Section - II carries 6 questions of 10 marks each. Answer any four questions in Section - II. 3 Use two separate answer books for the Section - I and Section - II. 4 Enter the question number clearly in the margin of the answer book beside each of your answer. SECTION - I Q1 Explain the following statement “For the phytochemist and pharmacognosist the knowledge of Ethnopharmacognosy and Ayurvedic system of medicines are a great opportunity”. 10 Q2 What is Homeopathy system of medicine Write Etymology and brief history of Homeopathy system of medicine. Write a brief note on Homeopathy medicine in Asia. 10 Q3 10 Q4 “The use of toxic herbs and of toxic metals and minerals as ingredients in traditional Ayurvedic treatments is a major safety concern” Explain the statement. 10

slide 36:

Q5 Enlist five drugs used in Ayurvedic medicine and homeopathic medicines. Give their comparative account. 10 Q6 10 a Rasa Shastra in Ayurvedic Practice. b The aim and practice of Panchakarma in a Ayurvedic system of Medicine. c Acupuncture. d Charaka Samhita. SECTION - II Q7 Define Churna. Write its method of preparation. What are characteristics of Churna Enlist four examples of Churna formulations along with their important therapeutic uses. 10 Q8 Define Taila. Write its method of preparation. What are characteristics of Taila Enlist four examples of Taila along with their important therapeutic uses. 10 Q9 What is Guggulu Explain the process of sodhana. What are the characteristics of Sodhita Guggulu How Sodhita Guggulu is stored and preserved 10 OR Write an exahustive note on “The aim and types of Rasayan in Ayurveda”. Q10Describe with illustrations the importance of microscopic physical chemical evaluation of Ayurvedic crude drugs. 10 Q11Write a brief note on Ayurvedic Skin care Cosmetics formulations. 10 Q12Write short note on any two : 10 a Ayurvedic Medicine : drug research and development critical issues. b General method of preparation of Ghruta. c Rasa Dhatu in Ayurveda. d Asava.

slide 37:

Total No. of Questions : 8 Total No. of Pages : 2 4056 - 117 M.Pharmacy Common to Sem. - I II NATURAL PRODUCT MANAGEMENT 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question No. 1 and 5 are compulsory. Out of remaining solve any 2 questions from section - I and any 2 questions from section - II. 2 Answers to the two sections should be written in separate answer books. SECTION - I Q1 Describe the detail method for processing of Cocoa and extraction of oil from Cocoa seed. 10 Q2 Explain various methods for Quality control of important Medicinal plants of India. 15 Q3 Explain the management of Land Labor and various equipments required in agriculture practices. 15 Q4 Write note on any three : 15 a International Trading of few Important Medicinal Plants. b Factors affecting marketing of natural products. c Cultivation protocol for Prioritized Medicinal Plants. d Capital resources for farm analysis/planning. SECTION - II Q5 Describe the facilities required to develop the Herbal Extraction Plant with reference to Schedule M. 10

slide 38:

Q6 15 Q7 Write the Global Regulatory affairs for herbal drugs. 15 Q8 Explain legal requirements and processing techniques for import and export of Medicine and Cosmetics. 15

slide 39:

Total No. of Questions : 8 Total No. of Pages : 2 4056-118 M.Pharmacy Common to Sem. - I Sem. - II MEDICINAL PLANT BIOTECHNOLOGY 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question No. 1 and 5 are compulsory. Out of the remaining attempt any two questions from Section-I and Section-II. 2 Figures to the right indicate full marks. P1687 SECTION - I Q1 Describe in detail role of plant tissue culture in biosynthesis of secondary metabolites. 10 Q2 a Explain plant cell immobilization. 8 b Enlist applications of recombinant DNA technology in production of biologicals. 7 Q3 a Describe in detail production of shikonin by plant cell culture. 8 b Describe hairy root and multiple shoot culture along with applications.7 Q4 Write notes on : 15 a Organ culture. b In situ germ plasm conservation. c Isolation of protoplast. SECTION - II Q5 Describe in detail methods of enzyme immobilization. 10 Q6 a Give an account of physical maps using in situ hybridization. 7 b Write about RAPD markers for genetic maping. 8 Q7 a Discuss insect resistance in transgenic plants. 8 b Give types and properties of enzymes. 7 P.T.O.

slide 40:

Q8 Write notes on : 15 a Molecular maps-RFLP. b Enzyme Purification. c Ti Plasmid. ⌧⌧⌧⌧ 4056-118 2

slide 41:

Total No. of Questions : 8 Total No. of Pages : 1 4056-201 M.Pharmacy Sem. - II DRUG REGULA TORY AFFAIRS 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question Nos. 1 and 5 are compulsory. Out of the remaining attempt two questions from Section-I and two questions from Section-II. 2 Answers to the two sections should be written in separate books. 3 Neat diagrams must be drawn wherever necessary. 4 Figures to the right indicate full marks. P1688 SECTION - I Q1 Explain in detail schedule-M. 10 Q2 a Give salient features of consumer Protection Act. 8 b Write in detail on preperation of first register under pharmacy Act. 7 Q3 Explain in detail provisions of DPCO. 15 Q4 Explain in detail structure and functioning of any three certifying agencies.15 SECTION - II Q5 Explain in detail concept of GCP. 10 Q6 Explain the concept of “Innovation” as applicable to patents. Give suitable examples. 15 Q7 Write in detail on any five general notices of I.P. 15 Q8 Write short notes on any three : 15 a DMF b Trade Marks c Pollution Control d GLP ⌧⌧⌧⌧

slide 42:

Total No. of Questions : 8 Total No. of Pages : 2 4056-202 M.Pharmacy Sem. - II FORMULA TIONS AND DEVELOPMENT 2008 Pattern Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question number 1 and 5 are compulsory. 2 Solve any two questions from the remaining in Section-I and Section-II. 3 Figures to the right indicate full marks. 4 Answers to the two sections should be written in separate answer books. P1689 SECTION - I Q1 Discuss in detail various approaches for taste masking formulations. 10 Q2 Explain in detail mucoadhesive drug delivery systems. 15 Q3 Elaborate on the various excipients used for gastroretention of formulations. 15 Q4 Write short notes on any three : 15 a Self micro emulsified drug delivery systems. b Pulsatile drug delivery systems. c Formulation of colon targeted drug delivery systems. d Emulgels based on niosomes. SECTION - II Q5 Explain in detail the advances in aerosol inhalation systems and add a note on components of aerosol valve. 10 Q6 Explain in detail nanopharmaceuticals. 15 P.T.O.

slide 43:

Q7 Explain need and problems of designing veterinary dosage forms. Add a note on specialized dose dispensers. 15 Q8 Write short notes on any three : 15 a Aerosol Propellants. b Manufacturing of aerosols. c Regulatory perspective of selection and evaluation of pharmaceutical packaging materials. d Multiple emulsion. ⌧⌧⌧⌧ 4056-202 2

slide 44:

Total No. of Questions : 8 Total No. of Pages : 2 4056-203 M.Pharmacy NOVEL DRUG DELIVERY SYSTEMS 2008 Pattern Sem. - II Time : 3 Hours Max. Marks : 80 Instructions to the candidates: 1 Question number 1 and 5 are compulsory. 2 Solve any two questions from the remaining in section-I and section-II. 3 Figures to the right indicate full marks. 4 Answers to the two sections should be written in separate answer books. P1690 SECTION - I Q1 Enlist the oral novel drug delivery systems. Describe the mechanism of push pull osmotic pump. 10 Q2 Give approaches to formulation of floating type gastric retentive drug delivery systems along with its evaluation. 15 Q3 What is mucoadhesion Describe the mechanism of mucoadhesion. Explain the evaluation methods for mucoadhesive DDS. 15 Q4 Write notes any two : 15 a Biodegradable microspheres. b Long acting contraceptive formulations. c Mechanism of transmucosal transport of drugs. SECTION - II Q5 Describe evaluation procedures for colon targeted drug delivery. 10 Q6 Describe different approaches to targeting drug delivery to brain. 15 Q7 Describe the protein and peptide drug delivery. Give its limitations. 15 P.T.O.

authorStream Live Help